Understand metrics of success, best practices, and collaborations for biomarker testing programs. Lynette M. Sholl, MD, covers tissue handling and pathology perspectives on turnaround time. Adam H. Fox, MD, MS, discusses reflex testing and multidisciplinary coordination to improve turnaround time, as well as the role of biomarker testing for earlier stages of lung cancer.
--
This non-CME education is brought to you by CHEST and sponsored by AstraZeneca.
Copyright for this content is held by the American College of Chest Physicians. Permission to redistribute is required.